Scientists Successfully Use Gold-Nanoparticles to Deliver Novel Therapy for Brain Tumor
In a recent publication in the Journal Science Translational Medicine, scientists from Northwestern University in Chicago used gold nanoparticles to deliver small interfering RNA (siRNA) against the Bcl2L12 oncogene. The study demonstrated in non-human primates, and in a small proof-of-concept clinical trial that the treatment can be safely administered, it travels to the brain and into the tumors. Importantly, the nanoparticles reduced the levels of Bcl2L12 and caused an increase in proteins associated with cell death.
GO Prime with only $1.49 now
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02